In this study, we discovered that activation of FGFR1 signaling significantly upregulates the oncogenic transcription factor FOXQ1 through the FGFR1-ERK2-c-FOS gene regulatory axis in breast cancer cells. This evidence concerns the gene MAPK1 and breast cancer.